Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 2/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15860864 | 0.90 | L3MBTL1 (0.41) | L3MBTL1KDM4EATMIL1R1MEN1 | |
| SCHEMBL17677089 | 0.89 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMIL1R1MEN1 | |
| SCHEMBL17689930 | 0.89 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMIL1R1MEN1 | |
| SCHEMBL15860696 | 0.87 | L3MBTL1 (0.32) | L3MBTL1KDM4EATMIL1R1MEN1 | |
| SCHEMBL15861031 | 0.87 | PTGER4 (0.34) | L3MBTL1KDM4EATM | |
| SCHEMBL15860855 | 0.87 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMIL1R1MEN1 | |
| SCHEMBL15860731 | 0.87 | AVPR1A (0.36) | L3MBTL1KDM4EATMIL1R1MEN1 | |
| SCHEMBL15860799 | 0.86 | PTGER4 (0.34) | L3MBTL1KDM4EATM | |
| SCHEMBL15860720 | 0.86 | L3MBTL1 (0.33) | L3MBTL1KDM4EATMIL1R1MEN1 | |
| SCHEMBL17245670 | 0.86 | KDM4E (0.41) | L3MBTL1KDM4EATMDUSP3PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140369933-A1 | FLUORINE-18 LABELED HYDROGEN ION PROBES | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2014-12-18 | — | — | US | disclosed |
| WO-2014104665-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT INCLUDING SAME | 주식회사 두산 (KR) | 2014-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140369933-A1 | FLUORINE-18 LABELED HYDROGEN ION PROBES | FUCA2, FUCA1, CD68 | L3MBTL1 881/4885KDM4E 3372/4885ATM 3510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.